A Phase 2 Study to Evaluate Pharmacokinetics, Safety and Efficacy of TMC114/Ritonavir (Rtv) in Human Immunodeficiency Virus (HIV)-1 Infected Children and Adolescents

Clinical trial NCT00355524 · COMPLETED

Trial details

NCT number: NCT00355524
Sponsor: Tibotec Pharmaceuticals, Ireland
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

HIV-1 HIV Infections

Start date: 2006-06-01
Primary completion: 2007-08-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.